CMV pneumonitis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

CMV pneumonitis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating CMV pneumonitis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
CMV pneumonitis overview On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of CMV pneumonitis overview All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on CMV pneumonitis overview
CDC on CMV pneumonitis overview
CMV pneumonitis overview in the news
Blogs on CMV pneumonitis overview
Directions to Hospitals Treating CMV pneumonitis
Risk calculators and risk factors for CMV pneumonitis overview

Overview

Cytomegalovirus (CMV) is a major cause of morbidity and mortality in immunocompromised hosts, and pneumonitis is a common manifestation of CMV infection. When immunocompromised patients present with fever and dyspnea, CMV pneumonitis should be a consideration.